BioNTech Receives Science Based Targets Initiative Validation For Near-Term Emissions Reduction Targets

BioNTech SE announces that the Company’s near-term science-based emissions reduction targets have been approved by the Science Based Targets initiative (“SBTi”). This validation underlines that BioNTech’s scope 1 and scope 2 climate targets are ambitious and in line with the United Nation’s Paris Climate Agreement to limit global warming to 1.5 degrees Celsius above pre-industrial levels.

“Our efforts to mitigate and manage the effects of climate change are embedded in our vision to help improve the health of people worldwide,” said Sierk Poetting, Ph.D., Chief Operating Officer at BioNTech. “Therefore, we seek to minimize the environmental impact of our business activities in our own operations and our entire value chain to positively impact patients, employees, communities, and ultimately, the planet.”

The SBTi has validated BioNTech’s near-term emission reduction targets in the following form:

• BioNTech commits to reduce absolute scope 1 and scope 2 greenhouse gas emissions 42% by 2030 from a 2021 base year.
• BioNTech commits that 72% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2027.

BioNTech aims to play an active role in climate change mitigation by reducing the emissions under its direct control (scope 1 and scope 2) and reducing indirect emissions in its supply chain (scope 3). To help enable the achievement of the Company's direct greenhouse gas emission reduction targets, a dedicated decarbonization department was established in 2022. In 2023, BioNTech implemented measures including planning and setting yearly reduction targets for the Company and its operational sites, monitoring its progress, and implementing decarbonization measures across the globe to support a pathway towards the Company’s 2030 target. In parallel, BioNTech continued its efforts to reduce scope 3 emissions in its supply chain. To this end, in 2023 the Company initiated dialogues with key suppliers aimed at Memoranda of Understanding that will outline these suppliers’ intent to set science-based emission reduction targets. More information on BioNTech’s Corporate Social Responsibility management can be found on the Company’s website (https://www.biontech.com/int/en/home/about/corporate-social-responsibility.html).